摘要
目的:观察急性非ST段抬高心肌梗死急诊患者不同诊疗方式的疗效,评价不同诊疗方式的临床应用价值。方法:回顾性分析我院急诊科于2007年1月～2010年3月收治抢救的急性非ST段抬高心肌梗死患者86例的临床资料,分析不同治疗方式的疗效及对预后的影响。结果:经皮冠状动脉腔内介入治疗(PCI)药物应用与普通药物治疗差异无统计学意义(P>0.05),临床疗效优于普通药物治疗,其心血管不良事件的发生率及死亡率也较普通药物治疗更低(P<0.05)。结论:普通药物联合经皮冠状动脉腔内介入治疗是治疗急性非ST段心肌梗死的有效手段,可明显改善近期预后。
Objective： To observe and valuate the efficacy of different treatments of acute non-ST-segment elevation myocardial infarction.Methods： 86 cases acute non-ST segment elevation myocardial infarction patients were retrospectively analyzed in emergency department of our hospital from January 2007 to March 2010.Then meta-analysis the efficacy of different treatment modalities and prognosis.Results： There had no significant difference between percutaneous transluminal coronary intervention（PCI） and general medical treatment of drug application（P0.05）,while clinical efficacy was superior to the general drug treatment.The incidence of cardiovascular events and mortality was also lower than the general drug treatment（P0.05）.Conclusion： It is an effective means of common drug combined transluminal percutaneous coronary intervention in treating acute non-ST segment myocardial infarction.It can improve the prognosis significantly.
出处
《中国医药导报》
CAS
2011年第21期41-43,共3页
China Medical Herald
关键词
心肌梗死
非ST段抬高
介入干预
Acute myocardial infarction
Non-ST-segment elevation
Intervention
